Tumors of the Skeletal System

Withrow and MacEwen's Small Animal Clinical Oncology: Fifth Edition

Volumn , Issue , 2012, Pages 463-503

  Ehrhart, Nicole P ^a   Ryan, Stewart D ^a,b   Fan, Timothy M ^c  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Surgical Consultancy Services Pty Ltd   (Australia)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887828897     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2362-5.00024-4     Document Type: Chapter

References (378)

1. Brodey RS, Mc GJ, Reynolds H A clinical and radiological study of canine bone neoplasms. I. J Am Vet Med Assoc 1959, 134:53-71.
2. Brodey RS, Riser WH Canine osteosarcoma: a clinicopathologic study of 194 cases. Clin Orthop Relat Res 1969, 62:54-64.
3. Brodey RS, Sauer RM, Medway W Canine bone neoplasms. J Am Vet Med Assoc 1963, 143:471-495.
4. Dorfman SK, Hurvitz AI, Patnaik AK Primary and secondary bone tumours in the dog. J Small Anim Pract 1977, 18:313-326.
5. Ling GV, Morgan JP, Pool RR Primary bone tumors in the dog: a combined clinical, radiographic, and histologic approach to early diagnosis. J Am Vet Med Assoc 1974, 165:55-67.
6. Priester WA, McKay FW The occurrence of tumors in domestic animals. Natl Cancer Inst Monogr 1980, 1-210.
7. Withrow SJ, Powers BE, Straw RC, et al. Comparative aspects of osteosarcoma: dog versus man. Clin Orthop Relat Res 1991, Sept(270):159-168.
8. Alexander JW, Patton CS Primary tumors of the skeletal system. Vet Clin North Am Small Anim Pract 1983, 13:181-195.
9. Brodey RS, Abt DA Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 1976, 168:1032-1035.
10. Jongeward SJ Primary bone tumors. Vet Clin North Am Small Anim Pract 1985, 15:609-641.
11. Knecht CD, Priester WA Musculoskeletal tumors in dogs. J Am Vet Med Assoc 1978, 172:72-74.
12. Misdorp W Skeletal osteosarcoma: animal model: canine osteosarcoma. Am J Pathol 1980, 98:285-288.
13. Misdorp W, Hart AA Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst 1979, 62:537-545.
14. Nielsen SW, Schroder JD, Smith DL The pathology of osteogenic sarcoma in dogs. J Am Vet Med Assoc 1954, 124:28-35.
15. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992, 200:995-999.
16. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991, 5:205-210.
17. Tjalma RA Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 1966, 36:1137-1150.
18. Wolke RE, Nielsen SW Site incidence of canine osteosarcoma. J Small Anim Pract 1966, 7:489-492.
19. Smith RL Osteosarcoma in dogs in the Brisbane area. Aust Vet Pract 1988, 18:97-100.
20. Phillips L, Hager D, Parker R, et al. Osteosarcoma with a pathologic fracture in a six-month-old dog. Vet Radiol 1986, 27:18-19.
21. Feeney DA, Johnston GR, Grindem CB, et al. Malignant neoplasia of canine ribs: clinical, radiographic, and pathologic findings. J Am Vet Med Assoc 1982, 180:927-933.
22. Heyman SJ, Diefenderfer DL, Goldschmidt MH, et al. Canine axial skeletal osteosarcoma. A retrospective study of 116 cases (1986 to 1989). Vet Surg 1992, 21:304-310.
23. Ru G, Terracini B, Glickman LT Host related risk factors for canine osteosarcoma. Vet J 1998, 156:31-39.
24. Cooley DM, Beranek BC, Schlittler DL, et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1434-1440.
25. Liptak JM, Dernell WS, Straw RC, et al. Proximal radial and distal humeral osteosarcoma in 12 dogs. J Am Anim Hosp Assoc 2004, 40:461-467.
26. Gamblin RM, Straw RC, Powers BE, et al. Primary osteosarcoma distal to the antebrachiocarpal and tarsocrural joints in nine dogs (1980-1992). J Am Anim Hosp Assoc 1995, 31:86-91.
27. Bleier T, Lewitschek HP, Reinacher M Canine osteosarcoma of the penile bone. J Vet Med A Physiol Pathol Clin Med 2003, 50:397-398.
28. Lucroy MD, Peck JN, Berry CR Osteosarcoma of the patella with pulmonary metastases in a dog. Vet Radiol Ultrasound 2001, 42:218-220.
29. LaRue SM, Withrow SJ, Wrigley RH Radiographic bone surveys in the evaluation of primary bone tumors in dogs. J Am Vet Med Assoc 1986, 188:514-516.
30. Bech-Nielsen S, Haskins ME, Reif JS, et al. Frequency of osteosarcoma among first-degree relatives of St. Bernard dogs. J Natl Cancer Inst 1978, 60:349-353.
31. Kuntz CA, Dernell WS, Powers BE, et al. Extraskeletal osteosarcomas in dogs: 14 cases. J Am Anim Hosp Assoc 1998, 34:26-30.
32. Langenbach A, Anderson MA, Dambach DM, et al. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). J Am Anim Hosp Assoc 1998, 34:113-120.
33. Patnaik AK Canine extraskeletal osteosarcoma and chondrosarcoma: a clinicopathologic study of 14 cases. Vet Pathol 1990, 27:46-55.
34. Ringenberg MA, Neitzel LE, Zachary JF Meningeal osteosarcoma in a dog. Vet Pathol 2000, 37:653-655.
35. Thamm DH, Mauldin EA, Edinger DT, et al. Primary osteosarcoma of the synovium in a dog. J Am Anim Hosp Assoc 2000, 36:326-331.
36. Owen LN Transplantation of canine osteosarcoma. Eur J Cancer 1969, 5:615-620.
37. Gellasch KL, Kalscheur VL, Clayton MK, et al. Fatigue microdamage in the radial predilection site for osteosarcoma in dogs. Am J Vet Res 2002, 63:896-899.
38. Bennett D, Campbell JR, Brown P Osteosarcoma associated with healed fractures. J Small Anim Pract 1979, 20:13-18.
39. Sinibaldi K, Rosen H, Liu SK, et al. Tumors associated with metallic implants in animals. Clin Orthop Relat Res 1976, 257-266.
40. Stevenson S, Hohn RB, Pohler OE, et al. Fracture-associated sarcoma in the dog. J Am Vet Med Assoc 1982, 180:1189-1196.
41. Rosin A, Rowland GN Undifferentiated sarcoma in a dog following chronic irritation by a metallic foreign body and concurrent infection. J Am Anim Hosp Assoc 1981, 17:593-598.
42. Knecht CD, Priester WA Osteosarcoma in dogs: a study of previous trauma, fracture, and fracture fixation. J Am Anim Hosp Assoc 1978, 14:82-84.
43. Vasseur PB, Stevenson S Osteosarcoma at the site of a cortical bone allograft in a dog. Vet Surg 1987, 16:70-74.
44. Gillette SM, Gillette EL, Powers BE, et al. Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy. Cancer Res 1990, 50:54-57.
45. Lloyd RD, Taylor GN, Angus W, et al. Distribution of skeletal malignancies in beagles injected with 239Pu citrate. Health Phys 1994, 66:407-413.
46. McEntee MC, Page RL, Theon A, et al. Malignant tumor formation in dogs previously irradiated for acanthomatous epulis. Vet Radiol Ultrasound 2004, 45:357-361.
47. Miller SC, Lloyd RD, Bruenger FW, et al. Comparisons of the skeletal locations of putative plutonium-induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species. Radiat Res 2003, 160:517-523.
48. Powers BE, Gillette EL, McChesney SL, et al. Bone necrosis and tumor induction following experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys 1989, 17:559-567.
49. Robinson E, Neugut AI, Wylie P Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988, 80:233-240.
50. Tillotson C, Rosenberg A, Gebhardt M, et al. Postradiation multicentric osteosarcoma. Cancer 1988, 62:67-71.
51. White RG, Raabe OG, Culbertson MR, et al. Bone sarcoma characteristics and distribution in beagles fed strontium-90. Radiat Res 1993, 136:178-189.
52. White RG, Raabe OG, Culbertson MR, et al. Bone sarcoma characteristics and distribution in beagles injected with radium-226. Radiat Res 1994, 137:361-370.
53. Dahlin DC, Coventry MB Osteogenic sarcoma: a study of six hundred cases. J Bone Joint Surg Am 1967, 49:101-110.
54. McKenna RJ, Schwinn CP, Higginbotham NL Osteogenic sarcoma in children. CA Cancer J Clin 1966, 16:26-28.
55. Dubielzig RR, Biery DN, Brodey RS Bone sarcomas associated with multifocal medullary bone infarction in dogs. J Am Vet Med Assoc 1981, 179:64-68.
56. Riser WH, Brodey RS, Biery DN Bone infarctions associated with malignant bone tumors in dogs. J Am Vet Med Assoc 1972, 160:414-421.
57. Prior C, Watrous BJ, Penfold D Radial diaphyseal osteosarcoma with associated bone infarction in a dog. J Am Anim Hosp Assoc 1986, 22:43-48.
58. Ansari MM Bone infarcts associated with malignant sarcomas. Comp Cont Ed Pract Vet 1991, 3:367-370.
59. Boulay J, Wallace L, Lipowitz A Pathologic fracture of long bones in the dog. J Am Anim Hosp Assoc 1987, 23:297-303.
60. Marcellin-Little DJ, DeYoung DJ, Thrall DE, et al. Osteosarcoma at the site of bone infarction associated with total hip arthroplasty in a dog. Vet Surg 1999, 28:54-60.
61. Holmberg BJ, Farese JP, Taylor D, et al. Osteosarcoma of the humeral head associated with osteochondritis dissecans in a dog. J Am Anim Hosp Assoc 2004, 40:246-249.
62. Barnhart MD Malignant transformation of an aneurysmal bone cyst in a dog. Vet Surg 2002, 31:519-524.
63. Johnson AS, Couto CG, Weghorst CM Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 1998, 19:213-217.
64. Kirpensteijn J, Kik M, Teske E, et al. TP53 gene mutations in canine osteosarcoma. Vet Surg 2008, 37:454-460.
65. Levine RA, Fleischli MA Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines. Vet Pathol 2000, 37:54-61.
66. Loukopoulos P, Thornton JR, Robinson WF Clinical and pathologic relevance of p53 index in canine osseous tumors. Vet Pathol 2003, 40:237-248.
67. Mendoza S, Konishi T, Dernell WS, et al. Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res 1998, 18:4449-4453.
68. Sagartz JE, Bodley WL, Gamblin RM, et al. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Vet Pathol 1996, 33:213-221.
69. Setoguchi A, Sakai T, Okuda M, et al. Aberrations of the p53 tumor suppressor gene in various tumors in dogs. Am J Vet Res 2001, 62:433-439.
70. van Leeuwen IS, Cornelisse CJ, Misdorp W, et al. P53 gene mutations in osteosarcomas in the dog. Cancer Lett 1997, 111:173-178.
71. Thomas R, Wang HJ, Tsai PC, et al. Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 2009, 17:365-377.
72. Levine AJ, Chang A, Dittmer D, et al. The p53 tumor suppressor gene. J Lab Clin Med 1994, 123:817-823.
73. Wadayama B, Toguchida J, Shimizu T, et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 1994, 54:3042-3048.
74. Levine RA, Forest T, Smith C Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors. Vet Pathol 2002, 39:372-378.
75. Angstadt AY, Motsinger-Reif A, Thomas R, et al. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes Chromosomes Cancer 2011, 50:859-874.
76. Phillips JC, Lembcke L, Chamberlin T A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26. Genomics 2010, 96:220-227.
77. Phillips JC, Stephenson B, Hauck M, et al. Heritability and segregation analysis of osteosarcoma in the Scottish deerhound. Genomics 2007, 90:354-363.
78. Urfer SR, Gaillard C, Steiger A Lifespan and disease predispositions in the Irish Wolfhound: a review. Vet Q 2007, 29:102-111.
79. Rosenberger JA, Pablo NV, Crawford PC Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005). J Am Vet Med Assoc 2007, 231:1076-1080.
80. Fox MH, Armstrong LW, Withrow SJ, et al. Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas. Cancer Res 1990, 50:6176-6178.
81. Liao AT, McCleese J, Kamerling S, et al. A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. Vet Comp Oncol 2007, 5:177-196.
82. Liao AT, McMahon M, London C Characterization, expression and function of c-Met in canine spontaneous cancers. Vet Comp Oncol 2005, 3:61-72.
83. MacEwen EG, Kutzke J, Carew J, et al. c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis 2003, 20:421-430.
84. Ferracini R, Angelini P, Cagliero E, et al. MET oncogene aberrant expression in canine osteosarcoma. J Orthop Res 2000, 18:253-256.
85. Liao AT, McMahon M, London CA Identification of a novel germline MET mutation in dogs. Anim Genet 2006, 37:248-252.
86. Fieten H, Spee B, Ijzer J, et al. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol 2009, 46:869-877.
87. MacEwen EG, Pastor J, Kutzke J, et al. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J Cell Biochem 2004, 92:77-91.
88. Khanna C, Prehn J, Hayden D, et al. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. Clin Cancer Res 2002, 8:2406-2412.
89. Gorlick R, Huvos AG, Heller G, et al. Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol 1999, 17:2781-2788.
90. Scotlandi K, Manara MC, Hattinger CM, et al. Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. Eur J Cancer 2005, 41:1349-1361.
91. Flint AF, U'Ren L, Legare ME, et al. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Vet Pathol 2004, 41:291-296.
92. Gordon IK, Ye F, Kent MS Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs. Am J Vet Res 2008, 69:1079-1084.
93. Paoloni MC, Mazcko C, Fox E, et al. Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs. PLoS One 2010, 5:e11013.
94. Fan TM, Barger AM, Sprandel IT, et al. Investigating TrkA expression in canine appendicular osteosarcoma. J Vet Intern Med 2008, 22:1181-1188.
95. Kow K, Bailey SM, Williams ES, et al. Telomerase activity in canine osteosarcoma. Vet Comp Oncol 2006, 4:184-187.
96. Kow K, Thamm DH, Terry J, et al. Impact of telomerase status on canine osteosarcoma patients. J Vet Intern Med 2008, 22:1366-1372.
97. Loukopoulos P, O'Brien T, Ghoddusi M, et al. Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res Vet Sci 2004, 77:131-141.
98. Barger AM, Fan TM, de Lorimier LP, et al. Expression of receptor activator of nuclear factor kappa-B ligand (RANKL) in neoplasms of dogs and cats. J Vet Intern Med 2007, 21:133-140.
99. Lana SE, Ogilvie GK, Hansen RA, et al. Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res 2000, 61:111-114.
100. Schmit JM, Pondenis HC, Barger AM, et al. Cathepsin k expression and activity in canine osteosarcoma. J Vet Intern Med 2012, 26:126-134.
101. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004, 10:182-186.
102. Fan TM, Barger AM, Fredrickson RL, et al. Investigating CXCR4 expression in canine appendicular osteosarcoma. J Vet Intern Med 2008, 22:602-608.
103. Barger A, Graca R, Bailey K, et al. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors. Vet Pathol 2005, 42:161-165.
104. Neihaus SA, Locke JE, Barger AM, et al. A novel method of core aspirate cytology compared to fine-needle aspiration for diagnosing canine osteosarcoma. J Am Anim Hosp Assoc 2011, 47:317-323.
105. Britt T, Clifford C, Barger A, et al. Diagnosing appendicular osteosarcoma with ultrasound-guided fine-needle aspiration: 36 cases. J Small Anim Pract 2007, 48:145-150.
106. Kirpensteijn J, Kik M, Rutteman GR, et al. Prognostic significance of a new histologic grading system for canine osteosarcoma. Vet Pathol 2002, 39:240-246.
107. O'Donoghue LE, Ptitsyn AA, Kamstock DA, et al. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome. BMC Cancer 2010, 10:506.
108. Bhandal J, Boston SE Pathologic fracture in dogs with suspected or confirmed osteosarcoma. Vet Surg 2011, 40:423-430.
109. Kim MS, Lee SY, Lee TR, et al. Prognostic effect of pathologic fracture in localized osteosarcoma: a cohort/case controlled study at a single institute. J Surg Oncol 2009, 100:233-239.
110. Ebeid W, Amin S, Abdelmegid A Limb salvage management of pathologic fractures of primary malignant bone tumors. Cancer Control 2005, 12:57-61.
111. Bacci G, Ferrari S, Longhi A, et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand 2003, 74:449-454.
112. Kuettner KE, Pauli BU, Soble L Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo. Cancer Res 1978, 38:277-287.
113. Brem H, Folkman J Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 1975, 141:427-439.
114. Hillers KR, Dernell WS, Lafferty MH, et al. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc 2005, 226:1364-1367.
115. Boston SE, Ehrhart NP, Dernell WS, et al. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004). J Am Vet Med Assoc 2006, 228:1905-1908.
116. Giuliano AE, Feig S, Eilber FR Changing metastatic patterns of osteosarcoma. Cancer 1984, 54:2160-2164.
117. Bacci G, Avella M, Picci P, et al. Metastatic patterns in osteosarcoma. Tumori 1988, 74:421-427.
118. Kaya M, Wada T, Nagoya S, et al. Concomitant tumour resistance in patients with osteosarcoma: a clue to a new therapeutic strategy. J Bone Joint Surg Br 2004, 86:143-147.
119. Tsunemi T, Nagoya S, Kaya M, et al. Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop 2003, 407:159-166.
120. Moore GE, Mathey WS, Eggers JS, et al. Osteosarcoma in adjacent lumbar vertebrae in a dog. J Am Vet Med Assoc 2000, 217:1038-1040. 1008.
121. Sajadi KR, Heck RK, Neel MD, et al. The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Relat Res 2004, 92-96.
122. Straw R, Powers BE, Klausner J, et al. Canine mandibular osteosarcoma: 51 cases (1980-1992). J Am Anim Hosp Assoc 1996, 32:257-262.
123. Dickerson ME, Page RL, LaDue TA, et al. Retrospective analysis of axial skeleton osteosarcoma in 22 large-breed dogs. J Vet Intern Med 2001, 15:120-124.
124. Mehl ML, Withrow SJ, Seguin B, et al. Spontaneous regression of osteosarcoma in four dogs. J Am Vet Med Assoc 2001, 219:614-617.
125. Mazzaferro EM, Hackett TB, Stein TP, et al. Metabolic alterations in dogs with osteosarcoma. Am J Vet Res 2001, 62:1234-1239.
126. Kazmierski KJ, Ogilvie GK, Fettman MJ, et al. Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. J Vet Intern Med 2001, 15:585-588.
127. Wrigley RH Malignant versus nonmalignant bone disease. Vet Clin North Am Small Anim Pract 2000, 30:315-347. vi-vii.
128. Reinhardt S, Stockhaus C, Teske E, et al. Assessment of cytological criteria for diagnosing osteosarcoma in dogs. J Small Anim Pract 2005, 46:65-70.
129. Samii VF, Nyland TG, Werner LL, et al. Ultrasound-guided fine-needle aspiration biopsy of bone lesions: a preliminary report. Vet Radiol Ultrasound 1999, 40:82-86.
130. Ehrhart N Principles of tumor biopsy. Clin Tech Small Anim Pract 1998, 13:10-16.
131. Mankin HJ, Lange TA, Spanier SS The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982, 64:1121-1127.
132. deSantos LA, Murray JA, Ayala AG The value of percutaneous needle biopsy in the management of primary bone tumors. Cancer 1979, 43:735-744.
133. Simon MA Biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1982, 64:1253-1257.
134. Wykes PM, Withrow SJ, Powers BE Closed biopsy for diagnosis of long bone tumors: accuracy and results. J Am Anim Hosp Assoc 1985, 21:489-494.
135. Powers BE, LaRue SM, Withrow SJ, et al. Jamshidi needle biopsy for diagnosis of bone lesions in small animals. J Am Vet Med Assoc 1988, 193:205-210.
136. Vignoli M, Ohlerth S, Rossi F, et al. Computed tomography-guided fine-needle aspiration and tissue-core biopsy of bone lesions in small animals. Vet Radiol Ultrasound 2004, 45:125-130.
137. Barthez PY, Hornof WJ, Theon AP, et al. Receiver operating characteristic curve analysis of the performance of various radiographic protocols when screening dogs for pulmonary metastases. J Am Vet Med Assoc 1994, 204:237-240.
138. Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique: a study of 51 patients with histological correlation. Ann Oncol 2001, 12:1601-1604.
139. Waters DJ, Coakley FV, Cohen MD, et al. The detection of pulmonary metastases by helical CT: a clinicopathologic study in dogs. J Comput Assist Tomogr 1998, 22:235-240.
140. Eberle N, Fork M, von Babo V, et al. Comparison of examination of thoracic radiographs and thoracic computed tomography in dogs with appendicular osteosarcoma. Vet Comp Oncol 2011, 9:131-140.
141. Straw RC, Cook NL, LaRue SM, et al. Radiographic bone surveys. J Am Vet Med Assoc 1989, 195:1458.
142. Berg J, Lamb CR, O'Callaghan MW Bone scintigraphy in the initial evaluation of dogs with primary bone tumors. J Am Vet Med Assoc 1990, 196:917-920.
143. Hahn KA, Hurd C, Cantwell HD Single-phase methylene diphosphate bone scintigraphy in the diagnostic evaluation of dogs with osteosarcoma. J Am Vet Med Assoc 1990, 196:1483-1486.
144. Jankowski MK, Steyn PF, Lana SE, et al. Nuclear scanning with 99mTc-HDP for the initial evaluation of osseous metastasis in canine osteosarcoma. Vet Comp Oncol 2003, 1:152-158.
145. Lamb CR Bone scintigraphy in small animals. J Am Vet Med Assoc 1987, 191:1616-1622.
146. Parchman MB, Flanders JA, Erb HN, et al. Nuclear medical bone imaging and targeted radiography for evaluation of skeletal neoplasms in 23 dogs. Vet Surg 1989, 18:454-458.
147. Enneking WF, Spanier SS, Goodman MA A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980, 106-120.
148. Lamb CR, Berg J, Bengtson AE Preoperative measurement of canine primary bone tumors, using radiography and bone scintigraphy. J Am Vet Med Assoc 1990, 196:1474-1478.
149. Leibman NF, Kuntz CA, Steyn PF, et al. Accuracy of radiography, nuclear scintigraphy, and histopathology for determining the proximal extent of distal radius osteosarcoma in dogs. Vet Surg 2001, 30:240-245.
150. Davis GJ, Kapatkin AS, Craig LE, et al. Comparison of radiography, computed tomography, and magnetic resonance imaging for evaluation of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 2002, 220:1171-1176.
151. Wallack ST, Wisner ER, Werner JA, et al. Accuracy of magnetic resonance imaging for estimating intramedullary osteosarcoma extent in pre-operative planning of canine limb-salvage procedures. Vet Radiol Ultrasound 2002, 43:432-441.
152. Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med 1996, 10:76-81.
153. Cho WH, Song WS, Jeon DG, et al. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations. Ann Surg Oncol 2010, 17:702-708.
154. Kuntz CA, Asselin TL, Dernell WS, et al. Limb salvage surgery for osteosarcoma of the proximal humerus: outcome in 17 dogs. Vet Surg 1998, 27:417-422.
155. Sottnik JL, Rao S, Lafferty MH, et al. Association of blood monocyte and lymphocyte count and disease-free interval in dogs with osteosarcoma. J Vet Intern Med 2010, 24:1439-1444.
156. Brostrom LA, Strander H, Nilsonne U Survival in osteosarcoma in relation to tumor size and location. Clin Orthop Relat Res 1982, 250-254.
157. Hammer AS, Weeren FR, Weisbrode SE, et al. Prognostic factors in dogs with osteosarcomas of the flat or irregular bones. J Am Anim Hosp Assoc 1995, 31:321-326.
158. Cooley DM, Waters DJ Skeletal neoplasms of small dogs: a retrospective study and literature review. J Am Anim Hosp Assoc 1997, 33:11-23.
159. Wallace J, Matthiesen DT, Patnaik AK Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 1992, 21:337-341.
160. Schwarz PD, Withrow SJ, Curtis CR, et al. Partial maxillary resection as a treatment for oral cancer in 61 dogs. J Am Anim Hosp Assoc 1991, 27:616-624.
161. Kosovsky JK, Matthiesen DT, Marretta SM, et al. Results of partial mandibulectomy for the treatment of oral tumors in 142 dogs. Vet Surg 1991, 20:397-401.
162. Beckwith K, Eickhoff J, Dernell WS, et al. Osteosarcoma of the canine head: a retrospective analysis of 136 cases (1991-2008). Veterinary Cancer Society 2010, 49. San Diego, CA.
163. Hendrix DV, Gelatt KN Diagnosis, treatment and outcome of orbital neoplasia in dogs: a retrospective study of 44 cases. J Small Anim Pract 2000, 41:105-108.
164. Duffaud F, Digue L, Baciuchka-Palmaro M, et al. Osteosarcomas of flat bones in adolescents and adults. Cancer 2000, 88:324-332.
165. Pirkey-Ehrhart N, Withrow SJ, Straw RC, et al. Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc 1995, 31:65-69.
166. Baines SJ, Lewis S, White RA Primary thoracic wall tumours of mesenchymal origin in dogs: a retrospective study of 46 cases. Vet Rec 2002, 150:335-339.
167. Montgomery RD, Henderson RA, Powers RD, et al. Retrospective study of 26 primary thoracic wall tumors in dogs. J Am Anim Hosp Assoc 1993, 29:68-72.
168. Matthiesen DT, Clark GN, Orsher RJ, et al. En bloc resection of primary rib tumors in 40 dogs. Vet Surg 1992, 21:201-204.
169. Trout NJ, Pavletic MM, Kraus KH Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 1995, 207:585-587.
170. Norton C, Drenen CM, Emms SG Subtotal scapulectomy as the treatment for scapular tumour in the dog: a report of six cases. Aust Vet J 2006, 84:364-366.
171. Montinaro V, Boston SE, Buracco P, et al. Evaluation of scapulectomy for primary bone tumors in 42 dogs: a Veterinary Society of Surgical Oncology (VSSO) retrospective study. Vet Surg 2012, Accepted for publication.
172. Dernell WS, Van Vechten BJ, Straw RC, et al. Outcome following treatment for vertebral tumors in 20 dogs. J Am Anim Hosp Assoc 2000, 36:245-251.
173. Garzotto CK, Berg J, Hoffmann WE, et al. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma. J Vet Intern Med 2000, 14:587-592.
174. Ehrhart N, Dernell WS, Hoffmann WE, et al. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). J Am Vet Med Assoc 1998, 213:1002-1006.
175. Moore AS, Dernell WS, Ogilvie GK, et al. Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. J Vet Intern Med 2007, 21:783-790.
176. McCleese JK, Bear MD, Kulp SK, et al. Met interacts with EGFR and Ron in canine osteosarcoma. Vet Comp Oncol 2011.
177. Mullins MN, Lana SE, Dernell WS, et al. Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med 2004, 18:859-865.
178. Shoeneman JK, Ehrhart EJ, Eickhoff JC, et al. Expression and function of survivin in canine osteosarcoma. Cancer Res 2012, 72:249-259.
179. Thamm DH, O'Brien MG, Vail DM Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma. Vet Comp Oncol 2008, 6:126-132.
180. Selvarajah GT, Kirpensteijn J, van Wolferen ME, et al. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Mol Cancer 2009, 8:72.
181. Scott MC, Sarver AL, Gavin KJ, et al. Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. Bone 2011, 49:356-367.
182. Biller BJ, Elmslie RE, Burnett RC, et al. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol 2007, 116:69-78.
183. O'Neill K, Guth A, Biller B, et al. Changes in regulatory T cells in dogs with cancer and associations with tumor type. J Vet Intern Med 2009, 23:875-881.
184. Rissetto KC, Rindt H, Selting KA, et al. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma. Vet Immunol Immunopathol 2010, 135:137-145.
185. Biller BJ, Guth A, Burton JH, et al. Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med 2010, 24:1118-1123.
186. Liptak JM, Dernell WS, Straw RC, et al. Intercalary bone grafts for joint and limb preservation in 17 dogs with high-grade malignant tumors of the diaphysis. Vet Surg 2004, 33:457-467.
187. Liptak JM, Dernell WS, Ehrhart N, et al. Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Vet Surg 2006, 35:518-533.
188. Liptak JM, Dernell WS, Lascelles BD, et al. Intraoperative extracorporeal irradiation for limb sparing in 13 dogs. Vet Surg 2004, 33:446-456.
189. Berg J, Weinstein MJ, Schelling SH, et al. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). J Am Vet Med Assoc 1992, 200:2005-2008.
190. LaRue SM, Withrow SJ, Powers BE, et al. Limb-sparing treatment for osteosarcoma in dogs. J Am Vet Med Assoc 1989, 195:1734-1744.
191. Thrall DE, Withrow SJ, Powers BE, et al. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: a dose response assay. Int J Radiat Oncol Biol Phys 1990, 18:1351-1357.
192. Vasseur P Limb preservation in dogs with primary bone tumors. Vet Clin North Am Small Anim Pract 1987, 17:889-903.
193. Withrow SJ, Thrall DE, Straw RC, et al. Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer 1993, 71:2484-2490.
194. Straw RC, Withrow SJ Limb-sparing surgery versus amputation for dogs with bone tumors. Vet Clin North Am Small Anim Pract 1996, 26:135-143.
195. Pooya HA, Seguin B, Mason DR, et al. Biomechanical comparison of cortical radial graft versus ulnar transposition graft limb-sparing techniques for the distal radial site in dogs. Vet Surg 2004, 33:301-308.
196. Seguin B, Walsh PJ, Mason DR, et al. Use of an ipsilateral vascularized ulnar transposition autograft for limb-sparing surgery of the distal radius in dogs: an anatomic and clinical study. Vet Surg 2003, 32:69-79.
197. Ehrhart N Longitudinal bone transport for treatment of primary bone tumors in dogs: technique description and outcome in 9 dogs. Vet Surg 2005, 34:24-34.
198. Tommasini M, Ehrhart N, Ferretti A, et al. Bone transport osteogenesis for limb salvage following resection of primary bone tumors: experience with 6 cases (1991-1996). Vet Comp Orthop Traumatol 2000, 23:43-51.
199. Ehrhart N, Eurell JA, Tommasini M, et al. Effect of cisplatin on bone transport osteogenesis in dogs. Am J Vet Res 2002, 63:703-711.
200. Rovesti GL, Bascucci M, Schmidt K, et al. Limb sparing using a double bone-transport technique for treatment of a distal tibial osteosarcoma in a dog. Vet Surg 2002, 31:70-77.
201. Buracco P, Morello E, Martano M, et al. Pasteurized tumoral autograft as a novel procedure for limb sparing in the dog: A clinical report. Vet Surg 2002, 31:525-532.
202. Morello E, Vasconi E, Martano M, et al. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases. Vet Surg 2003, 32:539-544.
203. Straw RC, Withrow SJ, Powers BE Primary osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 1991, 27:323-326.
204. Kirpensteijn J, Straw RC, Pardo AD, et al. Partial and total scapulectomy in the dog. J Am Anim Hosp Assoc 1994, 30:313-319.
205. Straw RC, Withrow SJ, Powers BE Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 1992, 21:183-188.
206. Lascelles BD, Thomson MJ, Dernell WS, et al. Combined dorsolateral and intraoral approach for the resection of tumors of the maxilla in the dog. J Am Anim Hosp Assoc 2003, 39:294-305.
207. O'Brien MG, Withrow SJ, Straw RC, et al. Total and partial orbitectomy for the treatment of periorbital tumors in 24 dogs and 6 cats: a retrospective study. Vet Surg 1996, 25:471-479.
208. VCOG: Retrospective study of 26 primary tumors of the osseous thoracic wall in dogs. J Am Anim Hosp Assoc 1993, 29:68-72.
209. Withrow SJ, Hirsch VM Owner response to amputation of a pet's leg. Vet Med Small Anim Clin 1979, 74:332. 334.
210. Carberry CA, Harvey HJ Owner satisfaction with limb amputation in dogs and cats. J Am Anim Hosp Assoc 1987, 23:227-232.
211. O'Brien MG, Withrow SJ, Straw RC Recent advances in the treatment of canine appendicular osteosarcoma. Comp Cont Ed Pract Vet 1993, 15:613-616.
212. Meyer MS, Spanier SS, Moser M, et al. Evaluating marrow margins for resection of osteosarcoma. A modern approach. Clin Orthop Relat Res 1999, 170-175.
213. Morello E, Buracco P, Martano M, et al. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. J Small Anim Pract 2001, 42:61-66.
214. Tomford WW, Doppelt SH, Mankin HJ, et al. 1983 bone bank procedures. Clin Orthop Relat Res 1983, 15-21.
215. Straw RC, Powers BE, Withrow SJ, et al. The effect of intramedullary polymethylmethacrylate on healing of intercalary cortical allografts in a canine model. J Orthop Res 1992, 10:434-439.
216. Kirpensteijn J, Steinheimer D, Park RD, et al. Comparison of cemented and non-cemented allografts for limb sparing procedures in dogs with osteosarcoma of the distal radius. Vet Comp Orthop Traumatol 1998, 11:178-184.
217. Dernell WS, Withrow SJ, Straw RC, et al. Clinical response to antibiotic impregnated polymethyl methacrylate bead implantation of dogs with severe infections after limb sparing with allograft replacement-18 cases (1994-1996). Vet Comp Orthop Traumatol 1998, 11:94-99.
218. Boston SE, Duerr F, Bacon N, et al. Intraoperative radiation for limb sparing of the distal aspect of the radius without transcarpal plating in five dogs. Vet Surg 2007, 36:314-323.
219. Oya N, Kokubo M, Mizowaki T, et al. Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int J Radiat Oncol Biol Phys 2001, 51:87-93.
220. Sakayama K, Kidani T, Fujibuchi T, et al. Definitive intraoperative radiotherapy for musculoskeletal sarcomas and malignant lymphoma in combination with surgical excision. Int J Clin Oncol 2003, 8:174-179.
221. Tsuboyama T, Toguchida J, Kotoura Y, et al. Intra-operative radiation therapy for osteosarcoma in the extremities. Int Orthop 2000, 24:202-207.
222. Farese JP, Milner R, Thompson MS, et al. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 2004, 225:1567-1572. 1548.
223. Van Ginkel RJ, Hoekstra HJ, Meutstege FJ, et al. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: assessment of short-term effects. J Surg Oncol 1995, 59:169-176.
224. Rossi CR, Pasquali S, Mocellin S, et al. Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol 2010, 17:3000-3007.
225. Deroose JP, van Geel AN, Burger JW, et al. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients. J Surg Oncol 2011.
226. Zachos TA, Aiken SW, DiResta GR, et al. Interstitial fluid pressure and blood flow in canine osteosarcoma and other tumors. Clin Orthop Relat Res 2001, 230-236.
227. Powers BE, Withrow SJ, Thrall DE, et al. Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma. Cancer 1991, 67:126-134.
228. Withrow SJ, Liptak JM, Straw RC, et al. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Ann Surg Oncol 2004, 11:705-713.
229. Lascelles BD, Dernell WS, Correa MT, et al. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol 2005, 12:1073-1083.
230. Jeys LM, Grimer RJ, Carter SR, et al. Post operative infection and increased survival in osteosarcoma patients: are they associated?. Ann Surg Oncol 2007, 14:2887-2895.
231. Sottnik JL, U'Ren LW, Thamm DH, et al. Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother 2010, 59:367-378.
232. Kramer A, Walsh PJ, Seguin B Hemipelvectomy in dogs and cats: technique overview, variations, and description. Vet Surg 2008, 37:413-419.
233. Chauvet AE, Hogge GS, Sandin JA, et al. Vertebrectomy, bone allograft fusion, and antitumor vaccination for the treatment of vertebral fibrosarcoma in a dog. Vet Surg 1999, 28:480-488.
234. Liptak JM, Pluhar GE, Dernell WS, et al. Limb-sparing surgery in a dog with osteosarcoma of the proximal femur. Vet Surg 2005, 34:71-77.
235. Fitzpatrick N, Smith TJ, Pendegrass CJ, et al. Intraosseous transcutaneous amputation prosthesis (ITAP) for limb salvage in 4 dogs. Vet Surg 2011, 40:909-925.
236. Drygas KA, Taylor R, Sidebotham CG, et al. Transcutaneous tibial implants: a surgical procedure for restoring ambulation after amputation of the distal aspect of the tibia in a dog. Vet Surg 2008, 37:322-327.
237. Liptak JM, Dernell WS, Rizzo SA, et al. Partial foot amputation in 11 dogs. J Am Anim Hosp Assoc 2005, 41:47-55.
238. Fox LE, Geoghegan SL, Davis LH, et al. Owner satisfaction with partial mandibulectomy or maxillectomy for treatment of oral tumors in 27 dogs. J Am Anim Hosp Assoc 1997, 33:25-31.
239. White RAS Mandibulectomy and maxillectomy in the dog: long-term survival in 100 cases. J Small Anim Pract 1991, 32:69-74.
240. Withrow SJ, Holmberg DL Mandibulectomy in the treatment of oral cancer. J Am Anim Hosp Assoc 1983, 19:273-286.
241. Gaitan-Yanguas M A study of the response of osteogenic sarcoma and adjacent normal tissues to radiation. Int J Radiat Oncol Biol Phys 1981, 7:593-595.
242. Caceres E, Zaharia M, Valdivia S, et al. Local control of osteogenic sarcoma by radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1984, 10:35-39.
243. Machak GN, Tkachev SI, Solovyev YN, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clinic Proc 2003, 78:147-155.
244. Walter CU, Dernell WS, LaRue SM, et al. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 2005, 3:1-7.
245. Liepe K Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer. Curr Opin Investig Drugs 2009, 10:1346-1358.
246. Nilsson S, Strang P, Ginman C, et al. Palliation of bone pain in prostate cancer using chemotherapy and strontium-89: a randomized phase II study. J Pain Symptom Manage 2005, 29:352-357.
247. Nilsson S, Franzen L, Parker C, et al. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. Lancet Oncol 2007, 8:587-594.
248. Vail DM, Kurzman ID, Glawe PC, et al. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial. Cancer Chemother Pharmacol 2002, 50:131-136.
249. Phillips B, Powers BE, Dernell WS, et al. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc 2009, 45:33-38.
250. Saam DE, Liptak JM, Stalker MJ, et al. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). J Am Vet Med Assoc 2011, 238:195-206.
251. Kirpensteijn J, Teske E, Kik M, et al. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation. Anticancer Res 2002, 22:2765-2770.
252. Berg J, Weinstein MJ, Springfield DS, et al. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 1995, 206:1555-1560.
253. Berg J, Gebhardt MC, Rand WM Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 1997, 79:1343-1350.
254. Chun R, Garrett LD, Henry C, et al. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am Anim Hosp Assoc 2005, 41:382-387.
255. Bailey D, Erb H, Williams L, et al. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. J Vet Intern Med 2003, 17:199-205.
256. Mauldin GN, Matus RE, Withrow SJ, et al. Canine osteosarcoma: treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988, 2:177-180.
257. Kent MS, Strom A, London CA, et al. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 2004, 18:540-544.
258. Bacon NJ, Ehrhart NP, Dernell WS, et al. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006). J Am Vet Med Assoc 2008, 232:1504-1510.
259. McMahon M, Mathie T, Stingle N, et al. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. J Vet Intern Med 2011, 25:511-517.
260. de la Puente-Redondo VA, Tilt N, Rowan TG, et al. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. Am J Vet Res 2007, 68:48-56.
261. Vail DM, Rodabaugh HS, Conder GA, et al. Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients. Vet Comp Oncol 2007, 5:38-46.
262. Ogilvie GK, Krawiec DR, Gelberg HB, et al. Evaluation of a short-term saline diuresis protocol for the administration of cisplatin. Am J Vet Res 1988, 49:1076-1078.
263. DeRegis CJ, Moore AS, Rand WM, et al. Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma. J Vet Intern Med 2003, 17:668-673.
264. McMahon MB, Bear MD, Kulp SK, et al. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. Am J Vet Res 2010, 71:799-808.
265. Selting KA, Wang X, Gustafson DL, et al. Evaluation of satraplatin in dogs with spontaneously occurring malignant tumors. J Vet Intern Med 2011, 25:909-915.
266. Kurzman ID, Shi F, Vail DM, et al. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells. Cancer Biother Radiopharm 1999, 14:121-128.
267. MacEwen EG, Kurzman ID, Rosenthal RC, et al. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. J Natl Cancer Inst 1989, 81:935-938.
268. Kurzman ID, MacEwen EG, Rosenthal RC, et al. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1995, 1:1595-1601.
269. Savage SA, Mirabello L Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011, 2011:548151.
270. Polednak AP Human biology and epidemiology of childhood bone cancers: a review. Hum Biol 1985, 57:1-26.
271. Downey RJ Surgical treatment of pulmonary metastases. Surg Oncol Clin N Am 1999, 8:341.
272. O'Brien MG, Straw RC, Withrow SJ, et al. Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983-1992). Vet Surg 1993, 22:105-109.
273. Liptak JM, Monnet E, Dernell WS, et al. Pulmonary metastasectomy in the management of four dogs with hypertrophic osteopathy. Vet Comp Oncol 2004, 2:1-12.
274. Lansdowne JL, Monnet E, Twedt DC, et al. Thoracoscopic lung lobectomy for treatment of lung tumors in dogs. Vet Surg 2005, 34:530-535.
275. Ogilvie GK, Straw RC, Jameson VJ, et al. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). J Am Vet Med Assoc 1993, 202:304-306.
276. Poirier VJ, Hershey AE, Burgess KE, et al. Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. J Vet Intern Med 2004, 18:219-222.
277. London CA, Hannah AL, Zadovoskaya R, et al. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 2003, 9:2755-2768.
278. London C, Mathie T, Stingle N, et al. Preliminary evidence for biologic activity of toceranib phosphate (Palladia) in solid tumours. Vet Comp Oncol 2011.
279. Wittenburg LA, Gustafson DL, Thamm DH Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Clin Cancer Res 2010, 16:4832-4842.
280. Hershey AE, Kurzman ID, Forrest LJ, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 1999, 5:2653-2659.
281. Rodriguez CO, Crabbs TA, Wilson DW, et al. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs. J Aerosol Med Pulm Drug Deliv 2010, 23:197-206.
282. Koshkina NV, Kleinerman ES Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer 2005, 116:458-463.
283. Khanna C, Anderson PM, Hasz DE, et al. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer 1997, 79:1409-1421.
284. Dow S, Elmslie R, Kurzman I, et al. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases. Hum Gene Ther 2005, 16:937-946.
285. Thamm DH, Kurzman ID, King I, et al. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin Cancer Res 2005, 11:4827-4834.
286. Portenoy RK Treatment of cancer pain. Lancet 2011, 377:2236-2247.
287. Clohisy DR, Mantyh PW Bone cancer pain. Clin Orthop Relat Res 2003, S279-S288.
288. Goblirsch MJ, Zwolak PP, Clohisy DR Biology of bone cancer pain. Clin Cancer Res 2006, 12:6231s-6235s.
289. Goblirsch M, Mathews W, Lynch C, et al. Radiation treatment decreases bone cancer pain, osteolysis and tumor size. Radiat Res 2004, 161:228-234.
290. Withrow SJ, Powers BE, Straw RC, et al. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma. Chir Organi Mov 1990, 75:29-31.
291. Green EM, Adams WM, Forrest LJ Four fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am Anim Hosp Assoc 2002, 38:445-451.
292. Knapp-Hoch HM, Fidel JL, Sellon RK, et al. An expedited palliative radiation protocol for lytic or proliferative lesions of appendicular bone in dogs. J Am Anim Hosp Assoc 2009, 45:24-32.
293. Mueller F, Poirier V, Melzer K, et al. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs. In Vivo 2005, 19:713-716.
294. Ramirez O, Dodge RK, Page RL, et al. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999, 40:517-522.
295. Bateman KE, Catton PA, Pennock PW, et al. 0-7-21 radiation therapy for the palliation of advanced cancer in dogs. J Vet Intern Med 1994, 8:394-399.
296. McEntee MC, Page RL, Novotney CA, et al. Palliative radiotherapy for canine appendicular osteosarcoma. Vet Radiol Ultrasound 1993, 34:367-370.
297. Holmes RA [153Sm]EDTMP: a potential therapy for bone cancer pain. Semin Nucl Med 1992, 22:41-45.
298. Serafini AN Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases. Cancer 2000, 88:2934-2939.
299. Aas M, Moe L, Gamlem H, et al. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP). Clin Cancer Res 1999, 5:3148s-3152s.
300. Barnard SM, Zuber RM, Moore AS Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005). J Am Vet Med Assoc 2007, 230:1877-1881.
301. Lattimer JC, Corwin LA, Stapleton J, et al. Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J Nucl Med 1990, 31:1316-1325.
302. Milner RJ, Dormehl I, Louw WK, et al. Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours. J S Afr Vet Assoc 1998, 69:12-17.
303. Lipton A New therapeutic agents for the treatment of bone diseases. Expert Opin Biol Ther 2005, 5:817-832.
304. Coleman RE Therapeutic use of bisphosphonates in oncology. BMJ 1994, 309:1233.
305. Coleman RE, McCloskey EV Bisphosphonates in oncology. Bone 2011, 49:71-76.
306. Carano A, Teitelbaum SL, Konsek JD, et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990, 85:456-461.
307. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995, 10:1478-1487.
308. Luckman SP, Hughes DE, Coxon FP, et al. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998, 13:581-589.
309. Ashton JA, Farese JP, Milner RJ, et al. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res 2005, 66:885-891.
310. Farese JP, Ashton J, Milner R, et al. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro. In Vitro Cell Dev Biol Anim 2004, 40:113-117.
311. Poirier VJ, Huelsmeyer MK, Kurzman ID, et al. The bisphosphonates alendronate and zoledronate are inhibitors of canine and human osteosarcoma cell growth in vitro. Vet Comp Oncol 2003, 1:207-215.
312. Tomlin JL, Sturgeon C, Pead MJ, et al. Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 2000, 147:129-132.
313. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J Vet Intern Med 2005, 19:74-80.
314. Fan TM, de Lorimier LP, O'Dell-Anderson K, et al. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. J Vet Intern Med 2007, 21:431-439.
315. Ryan SD, Timbie JW, Haussler KK, et al. Randomized, placebo-controlled, clinical trial of radiation therapy with or without pamidronate for palliative treatment of canine appendicular osteosarcoma. Vet Comp Oncol 2011, 9:e1-e49.
316. Fan TM, Charney SC, de Lorimier LP, et al. Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. J Vet Intern Med 2009, 23:152-160.
317. Spugnini EP, Vincenzi B, Caruso G, et al. Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. J Small Anim Pract 2009, 50:44-46.
318. Fan TM, de Lorimier LP, Garrett LD, et al. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. J Vet Intern Med 2008, 22:380-387.
319. Vail DM, MacEwen EG Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792.
320. Rowell JL, McCarthy DO, Alvarez CE Dog models of naturally occurring cancer. Trends Mol Med 2011, 17:380-388.
321. Withrow SJ, Wilkins RM Cross talk from pets to people: translational osteosarcoma treatments. ILAR J 2010, 51:208-213.
322. Mankin HJ, Hornicek FJ, Rosenberg AE, et al. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 2004, 286-291.
323. Wilkins RM, Cullen JW, Camozzi AB, et al. Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity. Clin Orthop Relat Res 2005, 438:128-136.
324. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli, according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000, 18:4016-4027.
325. Bacci G, Ruggieri P, Bertoni F, et al. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience. Oncol Rep 2000, 7:1129-1133.
326. Okada K, Unni KK, Swee RG, et al. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer 1999, 85:1044-1054.
327. Banks WC Parosteal osteosarcoma in a dog and a cat. J Am Vet Med Assoc 1971, 158:1412-1415.
328. Withrow SJ, Doige CE En block resection of a juxtacortical and three intra-osseous osteosarcomas of the zygomatic arch in dogs. J Am Anim Hosp Assoc 1980, 16:867-872.
329. Moores AP, Beck AL, Baker JF High-grade surface osteosarcoma in a dog. J Small Anim Pract 2003, 44:218-220.
330. Brodey RS, Misdorp W, Riser WH, et al. Canine skeletal chondrosarcoma: a clinicopathologic study of 35 cases. J Am Vet Med Assoc 1974, 165:68-78.
331. Sylvestre AM, Brash ML, Atilola MAO, et al. A case series of 25 dogs with chondrosarcoma. Vet Comp Orthop Traumatol 1992, 5:13-17.
332. Doige CE Multiple cartilaginous exostoses in dogs. Vet Pathol 1987, 24:276-278.
333. Gee BR, Doige CE Multiple cartilaginous exostoses in a litter of dogs. J Am Vet Med Assoc 1970, 156:53-59.
334. Doige CE, Pharr JW, Withrow SJ Chondrosarcoma arising in multiple cartilaginous exostosis in a dog. J Am Anim Hosp Assoc 1978, 14:605-611.
335. Popovitch CA, Weinstein MJ, Goldschmidt MH, et al. Chondrosarcoma: a retrospective study of 97 dogs (1987-1990). J Am Anim Hosp Assoc 1994, 30:81-85.
336. Anderson WI, Carberry CA, King JM, et al. Primary aortic chondrosarcoma in a dog. Vet Pathol 1988, 25:180-181.
337. Flanders JA, Castleman W, Carberry CA, et al. Laryngeal chondrosarcoma in a dog. J Am Vet Med Assoc 1987, 190:68-70.
338. Greenlee PG, Liu SK Chondrosarcoma of the mitral leaflet in a dog. Vet Pathol 1984, 21:540-542.
339. Southerland EM, Miller RT, Jones CL Primary right atrial chondrosarcoma in a dog. J Am Vet Med Assoc 1993, 203:1697-1698.
340. Weller RE, Dagle GE, Perry RL, et al. Primary pulmonary chondrosarcoma in a dog. Cornell Vet 1992, 82:447-452.
341. Patnaik AK, Mattiesen DT, Zawie DA Two cases of canine penile neoplasm: squamous cell carcinoma and mesenchymal chondrosarcoma. J Am Anim Hosp Assoc 1988, 24:403-406.
342. Aron DN, DeVreis R, Short CE Primary tracheal chondrosarcoma in a dog: a case report with description of surgical and anesthetic techniques. J Am Anim Hosp Assoc 1980, 16:31-37.
343. Lana SE, Dernell WS, LaRue SM, et al. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol Ultrasound 1997, 38:474-478.
344. Yamaguchi T, Toguchida J, Yamamuro T, et al. Allelotype analysis in osteosarcomas: Frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 1992, 52:2419-2423.
345. Bjornsson J, McLeod RA, Unni KK, et al. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998, 83:2105-2119.
346. Hammer AS, Couto CG, Filppi J, et al. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 1991, 5:160-166.
347. Ogilvie GK, Powers BE, Mallinckrodt CH, et al. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 1996, 10:379-384.
348. Vail DM, MacEwen EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res 1995, 1:1165-1170.
349. Wesselhoeft-Ablin LA, Berg RJ, Schelling SH Fibrosarcoma in the canine appendicular skeleton. J Am Anim Hosp Assoc 1991, 27:303-309.
350. Banks TA, Straw RC Multilobular osteochondrosarcoma of the hard palate in a dog. Aust Vet J 2004, 82:409-412.
351. Straw RC, LeCouteur RA, Powers BE, et al. Multilobular osteochondrosarcoma of the canine skull: 16 cases (1978-1988). J Am Vet Med Assoc 1989, 195:1764-1769.
352. Dernell WS, Straw RC, Cooper MF, et al. Multilobular osteochondrosarcoma in 39 dogs: 1979-1993. J Am Anim Hosp Assoc 1998, 34:11-18.
353. Hathcock JT, Newton JC Computed tomographic characteristics of multilobular tumor of bone involving the cranium in 7 dogs and zygomatic arch in 2 dogs. Vet Radiol Ultrasound 2000, 41:214-217.
354. Lipsitz D, Levitski RE, Berry WL Magnetic resonance imaging features of multilobular osteochondrosarcoma in 3 dogs. Vet Radiol Ultrasound 2001, 42:14-19.
355. Stoll MR, Roush JK, Moisan PG Multilobular tumour of bone with no abnormalities on plain radiography in a dog. J Small Anim Pract 2001, 42:453-455.
356. Cooley DM, Waters DJ Skeletal metastasis as the initial clinical manifestation of metastatic carcinoma in 19 dogs. J Vet Intern Med 1998, 12:288-293.
357. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 2000, 45:173-183.
358. Johnson KA, Cooley AJ, Darien DL Zygomatic osteoma with atypical heterogeneity in a dog. J Comp Pathol 1996, 114:199-203.
359. Chester DK Multiple cartilaginous exostoses in two generations of dogs. J Am Vet Med Assoc 1971, 159:895-897.
360. Hunt GB, Malik R, Johnson KA What is your diagnosis? Benign bone cyst in the distal portion of the left femur. J Am Vet Med Assoc 1991, 199:1071-1072.
361. Pernell RT, Dunstan RW, DeCamp CE Aneurysmal bone cyst in a six-month-old dog. J Am Vet Med Assoc 1992, 201:1897-1899.
362. Basher AWP, Doige CE, Presnell KR Subchondral bone cysts in a dog with osteochondrosis. J Am Anim Hosp Assoc 1988, 24:321-326.
363. Schrader SC, Burk RL, Liu SK Bone cysts in two dogs and a review of similar cystic bone lesions in the dog. J Am Vet Med Assoc 1983, 182:490-495.
364. Biery DN, Goldschmidt M, Riser WH, et al. Bone cysts in the dog. Vet Am Vet Radiol 1976, 17:202-212.
365. Grabias S, Mankin H Chondrosarcoma arising in histologically proved unicameral bone cyst. J Bone Joint Surg 1973, 56:1501-1503.
366. Dorn CR, Taylor DO, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968, 40:307-318.
367. Bitetto WV, Patnaik AK, Schrader SC, et al. Osteosarcoma in cats: 22 cases (1974-1984). J Am Vet Med Assoc 1987, 190:91-93.
368. Heldmann E, Anderson MA, Wagner-Mann C Feline osteosarcoma: 145 cases (1990-1995). J Am Anim Hosp Assoc 2000, 36:518-521.
369. Turrel JM, Pool RR Primary bone-tumors in the cat: a retrospective study of 15 cats and a literature-review. Vet Radiol 1982, 23:152-166.
370. Spugnini EP, Ruslander D, Bartolazzi A Extraskeletal osteosarcoma in a cat. J Am Vet Med Assoc 2001, 219:60-62. 49.
371. Stimson EL, Cook WT, Smith MM, et al. Extraskeletal osteosarcoma in the duodenum of a cat. J Am Anim Hosp Assoc 2000, 36:332-336.
372. Dhaliwal RS, Johnson TO, Kitchell BE Primary extraskeletal hepatic osteosarcoma in a cat. J Am Vet Med Assoc 2003, 222:340-342. 316.
373. Dimopoulou M, Kirpensteijn J, Moens H, et al. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma. Vet Surg 2008, 37:466-471.
374. Pool RR, Carrig CB Multiple cartilaginous exostoses in a cat. Vet Pathol 1972, 9:350-359.
375. Carpenter J, Andrews L, Holzworth J Tumors and tumor-like lesions. Diseases of the cat: medicine and surgery 1987, WB Saunders, Philadelphia. J. Holzworth (Ed.).
376. Liu SK, Dorfman HD, Patnaik AK Primary and secondary bone tumours in the cat. J Small Anim Pract 1974, 15:141-156.
377. Quigley PJ, Leedale AH Tumors involving bone in the domestic cat: a review of 58 cases. Vet Pathol 1983, 20:670-686.
378. Riddle WE, Leighton RL Osteochondromatosis in a cat. J Am Vet Med Assoc 1970, 156:1428-1430.